The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease

Lupus

Volumn 22, Issue 1, 2013, Pages 81-86

  Harward, L E ^a   Mitchell, K ^b   Pieper, C ^b   Copland, S ^b   Criscione Schreiber, L G ^b   Clowse, M E B ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cyclophosphamide; menopause; pregnancy; SLE

Indexed keywords

CYCLOPHOSPHAMIDE; GONADORELIN; GONADORELIN AGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FEMALE INFERTILITY; HUMAN; MENSTRUATION; NULLIPARA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTIVE PROCEDURE; RETROSPECTIVE STUDY; SCLERODERMA; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGE FACTORS; AMENORRHEA; CYCLOPHOSPHAMIDE; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILITY PRESERVATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY, FEMALE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENSTRUATION; PARITY; PREGNANCY; PREGNANCY RATE; PREMATURE BIRTH; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; VASCULITIS; YOUNG ADULT;

EID: 84871546147     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312468624     Document Type: Article

References (18)

1. Medeiros PB, Febronio MV, Bonfa E, Borba EF, Takiuti AD, Silva CA. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus. 2009 ; 18: 38-43
2. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus. 2000 ; 9: 401-405
3. Huong DL, Amoura Z, Duhaut P, et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol. 2002 ; 29: 2571-2576
4. Park MC, Park YB, Jung SY, Chung IH, Choi KH, Lee SK. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus. 2004 ; 13: 569-574
5. McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis. 1996 ; 55: 224-229
6. Brunner HI, Bishnoi A, Barron AC, et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus. 2006 ; 15: 198-206
7. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update. 2008 ; 14: 543-552
8. Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum. 2005 ; 52: 2761-2767
9. Clowse ME, Behera MA, Anders CK, et al. Ovarian preservation by GnRH agonists during chemotherapy: A meta-analysis. J Womens Health (Larchmt). 2009 ; 18: 311-319
10. Mok CC, Wong RW, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 1274-1280
11. Katsifis GE, Tzioufas AG. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus. 2004 ; 13: 673-678
12. Blumenfeld Z. GnRH-agonists in fertility preservation. Curr Opin Endocrinol Diabetes Obes. 2008 ; 15: 523-528
13. Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Pharmacological interventions for fertility preservation during chemotherapy: A systematic review and meta-analysis. Breast Cancer Res Treat. 2010 ; 122: 803-811
14. Behringer K, Breuer K, Reineke T, et al. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol. 2005 ; 23: 7555-7564
15. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558
16. Ledger WL. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab. 2010 ; 95: 5144-5154
17. Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008 ; 19: 340-347
18. Marder W, McCune WJ, Wang L, et al. Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients. Gynecol Endocrinol. 2012 ; 28: 624-627